Cogent Biosciences Inc (COGT)

02:47 AM

Cogent Biosciences (COGT) Projected to Post Earnings on Monday - Defense World

02:47 AM

Feb 21, 2025

Long Term Trading Analysis for (COGT) - Stock Traders Daily

Feb 21, 2025

Feb 14, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Down 5.9%Time to Sell? - MarketBeat

Feb 14, 2025

Feb 14, 2025

Leerink Partnrs Has Strong Forecast for COGT FY2025 Earnings - MarketBeat

Feb 14, 2025

Feb 13, 2025

You might want to take a look at Cogent Biosciences Inc (COGT) now - SETE News

Feb 13, 2025

Feb 11, 2025

Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Target Price at $14.33 - MarketBeat

Feb 11, 2025

Feb 11, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Down 5.9% – What’s Next? - Defense World

Feb 11, 2025

Feb 11, 2025

Investing in Cogent Biosciences Inc (COGT) might be an excellent idea, but the stock is currently overvalued/undervalued – US Post News - US Post News

Feb 11, 2025

Feb 11, 2025

Is Cogent Biosciences (COGT) Outperforming Other Medical Stocks This Year? - Nasdaq

Feb 11, 2025

Feb 11, 2025

Cogent Biosciences (NASDAQ:COGT) Sees Strong Trading VolumeWhat's Next? - MarketBeat

Feb 11, 2025

Feb 11, 2025

FY2025 Earnings Estimate for COGT Issued By Leerink Partnrs - Defense World

Feb 11, 2025

Feb 11, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.33 Consensus PT from Brokerages - Defense World

Feb 11, 2025

Feb 11, 2025

Cogent Biosciences Announces Bezuclastinib Poster in - GlobeNewswire

Feb 11, 2025

Feb 10, 2025

Cogent Biosciences Announces Bezuclastinib Poster in NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 2025 AAAAI Annual Meeting - The Manila Times

Feb 10, 2025

Feb 10, 2025

Cogent Biosciences to Present Long-Term Efficacy Results of Bezuclastinib at AAAAI Annual Meeting 2025 - Nasdaq

Feb 10, 2025

Feb 10, 2025

Cogent's NonAdvSM Treatment Shows Long-Term Patient BenefitsKey Data Coming at AAAAI 2025 - StockTitan

Feb 10, 2025

Feb 09, 2025

One Cogent Biosciences Insider Raised Stake By 2,085% In Previous Year - Simply Wall St

Feb 09, 2025

Feb 08, 2025

Analysts Issue Forecasts for COGT Q1 Earnings - Defense World

Feb 08, 2025

Feb 07, 2025

Cogent Biosciences Inc [COGT] gain 17.56% so far this year. What now? - The DBT News

Feb 07, 2025

Feb 07, 2025

A company insider recently bought 43,750 shares of Cogent Biosciences Inc [COGT]. Should You Buy? - Knox Daily

Feb 07, 2025

Feb 05, 2025

Analytical Overview: Cogent Biosciences Inc (COGT)’s Ratios Tell a Financial Story - The Dwinnex

Feb 05, 2025

Feb 05, 2025

Short Interest in Cogent Biosciences, Inc. (NASDAQ:COGT) Expands By 9.3% - MarketBeat

Feb 05, 2025

Feb 04, 2025

A year in review: Cogent Biosciences Inc (COGT)’s performance in the last year - US Post News

Feb 04, 2025

Feb 04, 2025

Cogent Biosciences Inc (COGT) Becoming More Attractive for Investors - Knox Daily

Feb 04, 2025

Feb 03, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Down 5.3%What's Next? - MarketBeat

Feb 03, 2025

Jan 31, 2025

Cogent Biosciences to Participate in the Guggenheim Biotech Conference - GlobeNewswire

Jan 31, 2025

Jan 30, 2025

Inside Cogent's Next Big Move: Key Presentation Set for Guggenheim Conference - StockTitan

Jan 30, 2025

Jan 30, 2025

How the (COGT) price action is used to our Advantage - Stock Traders Daily

Jan 30, 2025

Jan 27, 2025

JPMorgan Chase & Co. Buys 5,720 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jan 27, 2025

Jan 25, 2025

Cogent Biosciences (NASDAQ:COGT) Shares Down 4.2%Here's Why - MarketBeat

Jan 25, 2025

Jan 24, 2025

Cogent Biosciences (NASDAQ:COGT) Trading Up 7.3%Still a Buy? - MarketBeat

Jan 24, 2025

Jan 24, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Shares Purchased by SG Americas Securities LLC - MarketBeat

Jan 24, 2025

Jan 22, 2025

Assenagon Asset Management S.A. Sells 133,515 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - Defense World

Jan 22, 2025

Jan 20, 2025

Cogent and ModivCare gain after insider purchases - MSN

Jan 20, 2025

Jan 19, 2025

How to Take Advantage of moves in (COGT) - Stock Traders Daily

Jan 19, 2025

Jan 19, 2025

Cogent Biosciences Appoints James P. Geygan as Independent Director - Defense World

Jan 19, 2025

Jan 18, 2025

Hennion & Walsh Asset Management Inc. Buys 103,293 Shares of Cogent Biosciences, Inc. (NASDAQ:COGT) - MarketBeat

Jan 18, 2025

Jan 18, 2025

Cogent Biosciences: Buy The Pullback For Bezuclastinib's 2025 SM And GIST Data - Seeking Alpha

Jan 18, 2025

Jan 17, 2025

This Cogent Biosciences Insider Increased Their Holding By 2,085% Last Year - Yahoo Finance

Jan 17, 2025

Jan 17, 2025

Cole Pinnow Bought 2,085% More Shares In Cogent Biosciences - Yahoo Finance

Jan 17, 2025

Jan 17, 2025

HC Wainwright Cuts Cogent Biosciences (NASDAQ:COGT) Price Target to $14.00 - Defense World

Jan 17, 2025

Jan 17, 2025

Brokerages Set Cogent Biosciences, Inc. (NASDAQ:COGT) Price Target at $14.83 - Defense World

Jan 17, 2025

Jan 15, 2025

Cogent Biosciences chief commercial officer buys $332,412 in stock By Investing.com - Investing.com Canada

Jan 15, 2025

Jan 15, 2025

Cogent stock ModivCare stock up on insider buys (COGT:NASDAQ) - Seeking Alpha

Jan 15, 2025

Jan 15, 2025

Cogent Biosciences (NASDAQ:COGT) Shares Gap UpHere's What Happened - MarketBeat

Jan 15, 2025

Jan 15, 2025

Cogent Biosciences chief commercial officer buys $332,412 in stock - Investing.com

Jan 15, 2025

Jan 15, 2025

Wednesday 1/15 Insider Buying Report: COGT, GBIO - Nasdaq

Jan 15, 2025

Jan 14, 2025

HC Wainwright Has Lowered Expectations for Cogent Biosciences (NASDAQ:COGT) Stock Price - MarketBeat

Jan 14, 2025

Jan 14, 2025

Cogent Biosciences, Inc. (NASDAQ:COGT) Receives $14.83 Average Target Price from Analysts - MarketBeat

Jan 14, 2025

Jan 14, 2025

Cogent Biosciences (NASDAQ:COGT) Receives Neutral Rating from Wedbush - Defense World

Jan 14, 2025